AI regulation

Leaders of government public policy at HIMSS are prioritizing health equity, AI regulation, cybersecurity and workforce development while urging unified policies that support healthcare innovation.

The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.

The EU guidelines highlight prohibitions on harmful manipulation, real-time biometric identification and social scoring.

President Trump revoked Joe Biden's 2023 order, which required HHS to establish an AI safety program and developers to share test results, among other directives.

At an event outside JPM, which included a representative from HHS, panelists discussed the government's role in advancing AI and the evolving healthcare landscape as a new administration transitions into power.

The Agency says AI can transform multiple aspects of healthcare, but it is difficult to fully oversee and regulate the technology without the assistance of all sectors involved.

The Act is the world's first major law for AI implementation and provides regulations for high-risk applications of the technology, including its use in healthcare.

Harjinder Sandhu, Microsoft CTO of health platforms and solutions, discusses the readiness of OpenAI for use in healthcare, bias within AI and GPT-4, and recommendations for regulators.  

Amazon Web Services chief medical officer Dr. Jared Saul relays how AWS helps the life sciences sector leverage AI and machine learning for drug discovery, concerns around AI/ML use in healthcare, and the value of regulating the technology.  

Bryant Godfrey, partner and cochair of healthcare and FDA practice groups at Foley Hoag, discusses the various agencies regulating AI in healthcare, potential inconsistencies in frameworks and expectations for regulation in the coming year.